CEPI and Korea discuss future of AI-driven international health cooperation

Source Domain: cepi.net

Seminar held at the National Assemblydiscussed strategic link between AI technology and Health ODA
CEPI expects Korea to play a leading role in the new AI platform, Pandemic Preparedness Engine
Consensus reached among Korean government, National Assembly, international organisations and industry to expand AI-enabled Health ODA

OSLO/SEOUL, February 4, 2026: The pandemic preparedness organisation, CEPI, in partnership with the National Assembly Global Sustainable Development and Humanitarian Forum (GSDHF) and the Korean Parliamentarian Forum on Global Health (KPFGH), held a seminar on February 4 at the National Assembly of the Republic of Korea discussing new directions for health Official Development Assistance (ODA) in the era of Artificial Intelligence (AI). The event highlighted positioning the Republic of Korea as a global hub for AI and health through bringing together its work across AI and the biosciences sectors.

Hosted by the National Assembly and co-organised by the Ministry of Foreign Affairs (MOFA), the Korea Disease Control and Prevention Agency (KDCA), and CEPI (the Coalition for Epidemic Preparedness Innovations), the event was convened to explore new models of health cooperation that could harness AI to move beyond traditional aid methods and strengthen Korea’s role in vaccine R&D and pandemic preparedness.

Approximately 100 participants attended the event, including members of the National Assembly Assemblyperson Jaejung Lee and Jumin Park, and other members from both Forums (Assemblypersons Miae Kim, Yoon Kim, Hyeryeon Baek, Kangil Lee, Sujin Lee, Jiho Cha, and Boyoon Choi). In addition, officials from the Office for Government Policy Coordination, MOFA, KDCA, the Ministry of Science and ICT and the Korea Institute of Science and Technology Information (KISTI) were also in attendance.

During his keynote presentation, Dr. Richard Hatchett, CEO of CEPI, highlighted that SK bioscience’s SKYCovione ™ COVID-19 vaccine– developed…

Source